Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 USD | +1.49% | +6.99% | -28.58% |
Strengths
- The company shows low valuation levels, with an enterprise value at 0.2 times its sales.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-28.58% | 337M | - | ||
-5.91% | 456B | B- | ||
+13.93% | 125B | A- | ||
+18.37% | 101B | B- | ||
-0.28% | 39.69B | B- | ||
-33.18% | 36.86B | A- | ||
-5.28% | 20.05B | B- | ||
-13.82% | 3.08B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CLOV Stock
- Ratings Clover Health Investments, Corp.